XHR · Insider Trading
Xenia Hotels & Resorts, Inc.
Every open-market purchase and sale reported by XHR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | Arlene Isaacs-Lowe | Director | A | +6,098 deriv. | — |
| 2026-05-15 | Thomas M Gartland | Director | A | +6,098 deriv. | — |
| 2026-05-15 | Beverly K. Goulet | Director | A | +6,098 deriv. | — |
| 2026-05-15 | Dennis D Oklak | Director | A | +6,098 deriv. | — |
| 2026-05-15 | Keith E Bass | Director | A | +6,098 deriv. | — |
| 2026-05-15 | Mary E McCormick | Director | A | +6,098 deriv. | — |
| 2026-05-15 | Terrence Moorehead | Director | A | +6,098 deriv. | — |
| 2026-05-11 | Atish Shah | See remarks | Sell | −120,000 | −$2.04M |
| 2026-05-07 | Joseph T Johnson | See Remarks | Sell | −24,916 | −$415.75K |
| 2026-02-26 | Taylor C. Kessel | See Remarks | A | +14,160 deriv. | — |
| 2026-02-26 | Atish Shah | See remarks | A | +23,600 deriv. | — |
| 2026-02-26 | Marcel Verbaas | See Remarks | A | +55,853 deriv. | — |
| 2026-02-26 | Joseph T Johnson | See Remarks | A | +9,047 deriv. | — |
| 2026-02-26 | Barry A N Bloom | See Remarks | Sell | −202,508 | −$3.18M |
| 2026-01-08 | Marcel Verbaas | See Remarks | A | +347,688 deriv. | — |
| 2026-01-08 | Atish Shah | See remarks | A | +131,012 deriv. | — |
| 2026-01-08 | Taylor C. Kessel | See Remarks | A | +80,622 deriv. | — |
| 2026-01-08 | Joseph T Johnson | See Remarks | A | +55,428 deriv. | — |
| 2026-01-08 | Barry A N Bloom | See Remarks | A | +171,324 deriv. | — |
| 2025-05-14 | Beverly K. Goulet | Director | A | +8,117 deriv. | — |
| 2025-05-14 | Mary E McCormick | Director | A | +8,117 deriv. | — |
| 2025-05-14 | Dennis D Oklak | Director | A | +8,117 deriv. | — |
| 2025-05-14 | Arlene Isaacs-Lowe | Director | A | +8,117 deriv. | — |
| 2025-05-14 | Terrence Moorehead | Director | A | +8,117 deriv. | — |
| 2025-05-14 | Thomas M Gartland | Director | A | +8,117 deriv. | — |
| 2025-05-14 | Keith E Bass | Director | A | +8,117 deriv. | — |
| 2025-02-26 | Barry A N Bloom | See Remarks | A | +31,560 deriv. | — |
| 2025-02-26 | Atish Shah | See remarks | A | +26,150 deriv. | — |
| 2025-02-26 | Taylor C. Kessel | See Remarks | A | +15,780 deriv. | — |
| 2025-02-26 | Joseph T Johnson | See Remarks | A | +10,370 deriv. | — |
| 2025-02-26 | Marcel Verbaas | See Remarks | A | +64,022 deriv. | — |
| 2025-01-21 | Atish Shah | See remarks | M | +42,826 | — |
| 2025-01-10 | Taylor C. Kessel | See Remarks | A | +16,587 deriv. | — |
| 2025-01-10 | Joseph T Johnson | See Remarks | A | +13,033 deriv. | — |
| 2025-01-10 | Atish Shah | See remarks | A | +30,807 deriv. | — |
| 2025-01-10 | Marcel Verbaas | See Remarks | A | +75,834 deriv. | — |
| 2025-01-10 | Barry A N Bloom | See Remarks | A | +40,287 deriv. | — |
| 2024-05-15 | Arlene Isaacs-Lowe | Director | A | +6,766 deriv. | — |
| 2024-05-15 | Terrence Moorehead | Director | A | +6,766 deriv. | — |
| 2024-05-15 | Mary E McCormick | Director | A | +6,766 deriv. | — |
| 2024-05-15 | Beverly K. Goulet | Director | A | +6,766 deriv. | — |
| 2024-05-15 | Dennis D Oklak | Director | A | +6,766 deriv. | — |
| 2024-05-15 | Thomas M Gartland | Director | A | +6,766 deriv. | — |
| 2024-05-15 | Keith E Bass | Director | A | +6,766 deriv. | — |
| 2024-02-27 | Barry A N Bloom | See Remarks | A | +32,010 deriv. | — |
| 2024-02-27 | Joseph T Johnson | See Remarks | A | +10,827 deriv. | — |
| 2024-02-27 | Marcel Verbaas | See Remarks | A | +64,960 deriv. | — |
| 2024-02-27 | Atish Shah | See remarks | A | +25,419 deriv. | — |
| 2024-02-27 | Taylor C. Kessel | See Remarks | A | +16,005 deriv. | — |
| 2024-01-10 | Atish Shah | See remarks | A | +16,460 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Marcel Verbaas | See Remarks | 269,796 | $5.35M |
| Atish Shah | See remarks | 250,805 | $4.98M |
| Barry A N Bloom | See Remarks | 167,142 | $3.32M |
| Joseph T Johnson | See Remarks | 65,396 | $1.30M |
| Taylor C. Kessel | See Remarks | 30,010 | $595.40K |
| Thomas M Gartland | Director | 10,850 | $215.26K |
| Mary E McCormick | Director | 8,250 | $163.68K |
| Keith E Bass | Director | 7,150 | $141.86K |
| Terrence Moorehead | Director | 5,138 | $101.94K |
| Dennis D Oklak | Director | 3,650 | $72.42K |
| Beverly K. Goulet | Director | 3,650 | $72.42K |
| Arlene Isaacs-Lowe | Director | 451 | $8.95K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the XHR quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.